CareDx Inc (CDNA) Stock Analysis
Verdict: HOLD
Reimbursement recovery and 70.6% margins drive strong earnings beats, but extreme 2.62 beta and heavy insider selling cap near-term upside.
Investment score: 61/100
Analysis as of
Is CareDx Inc stock worth reviewing? AI model thesis
CareDx demonstrates accelerating earnings growth and robust gross margins, but current pricing near 52-week highs ($54.16 vs $55.16 high) limits 90-day risk-reward.
7-factor investment score
- Valuation: 50/100 (weight 20%)
- Financial Health: 80/100 (weight 15%)
- Technical Momentum: 82/100 (weight 15%)
- Earnings Quality: 75/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 68/100 (weight 10%)
- Risk-Adjusted Return: 45/100 (weight 15%)
CareDx Inc opportunities and risks
What speaks for CDNA
- Sustained gross margin expansion from high-value testing platforms
What speaks against CDNA
- Reimbursement and Medicare policy concentration risks
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| CDNA | 25.2x | 6.1x | 157.4x | 70.6% | 24.2% | 3.0% |
| VCYT | 27.5x | 5.6x | 22.4x | 72.1% | 20.4% | 5.2% |
| CLDX | n/a | 23650.9x | n/a | -56850.9% | -268385.7% | -9.1% |
| ARQT | 112.1x | 6.7x | 72.0x | 91.1% | 6.1% | 1.3% |
| PURR | 19.4x | 179.6x | n/a | 100.0% | 3358.6% | -1.1% |
| PGEN | n/a | 32.4x | n/a | 89.6% | -184.0% | -4.2% |
| Peer median | 19.4x | 32.4x | n/a | 89.6% | 6.1% | -1.1% |
Frequently asked questions about CareDx Inc (CDNA)
Is CDNA stock a good investment?
The cached TradeMates AI model rates CareDx Inc as HOLD with an investment score of 61/100. CareDx demonstrates accelerating earnings growth and robust gross margins, but current pricing near 52-week highs ($54.16 vs $55.16 high) limits 90-day risk-reward. This is algorithmic model output, not personal investment advice.
Is CDNA stock a buy?
The TradeMates model verdict for CDNA is HOLD with an investment score of 61/100. Treat this as a model signal to review, not a personal buy recommendation.